A.L. Zakharenko
Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topoteсan on in vivo tumor models
Zakharenko, A.L.; Luzina, O.A.; Sokolov, D.N.; Kaledin, V.I.; Nikolin, V.P.; Popova, N.A.; Patel, J.; Zakharova, O.D.; Chepanova, A.A.; Zafar, A.; Reynisson, J.; Leung, E.; Leung, I.K.H.; Volcho, K.P.; Salakhutdinov, N.F.; Lavrik, O.I.
Authors
O.A. Luzina
D.N. Sokolov
V.I. Kaledin
V.P. Nikolin
N.A. Popova
J. Patel
O.D. Zakharova
A.A. Chepanova
A. Zafar
Johannes Reynisson j.reynisson@keele.ac.uk
E. Leung
I.K.H. Leung
K.P. Volcho
N.F. Salakhutdinov
O.I. Lavrik
Citation
Zakharenko, A., Luzina, O., Sokolov, D., Kaledin, V., Nikolin, V., Popova, N., Patel, J., Zakharova, O., Chepanova, A., Zafar, A., Reynisson, J., Leung, E., Leung, I., Volcho, K., Salakhutdinov, N., & Lavrik, O. (2019). Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topoteсan on in vivo tumor models. European Journal of Medicinal Chemistry, 161, 581-593. https://doi.org/10.1016/j.ejmech.2018.10.055
Journal Article Type | Article |
---|---|
Publication Date | 2019-01 |
Deposit Date | Jun 14, 2023 |
Journal | European Journal of Medicinal Chemistry |
Print ISSN | 0223-5234 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 161 |
Pages | 581-593 |
DOI | https://doi.org/10.1016/j.ejmech.2018.10.055 |
Keywords | Organic Chemistry; Drug Discovery; Pharmacology; General Medicine |
Public URL | https://keele-repository.worktribe.com/output/452121 |
Additional Information | This article is maintained by: Elsevier; Article Title: Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topoteсan on in vivo tumor models; Journal Title: European Journal of Medicinal Chemistry; CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ejmech.2018.10.055; Content Type: article; Copyright: © 2018 Elsevier Masson SAS. All rights reserved. |
You might also like
Accessing active fragments for drug discovery utilising nitroreductase biocatalysis.
(2024)
Journal Article
Phosphatidylcholine-Specific Phospholipase C as a Promising Drug Target
(2023)
Journal Article